Form 8-K - Current report:
SEC Accession No. 0001790340-25-000012
Filing Date
2025-01-07
Accepted
2025-01-07 08:26:10
Documents
13
Period of Report
2025-01-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20250107.htm   iXBRL 8-K 31210
  Complete submission text file 0001790340-25-000012.txt   164615

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20250107.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20250107_lab.xml EX-101.LAB 23705
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20250107_pre.xml EX-101.PRE 13601
15 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20250107_htm.xml XML 2922
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 25513525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)